<SEC-DOCUMENT>0001683168-21-003188-index.html : 20210730
<SEC-HEADER>0001683168-21-003188.hdr.sgml : 20210730
<ACCEPTANCE-DATETIME>20210730173027
ACCESSION NUMBER:		0001683168-21-003188
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210730
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210730
DATE AS OF CHANGE:		20210730

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sonoma Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001367083
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680423298
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33216
		FILM NUMBER:		211133779

	BUSINESS ADDRESS:	
		STREET 1:		645 MOLLY LANE, SUITE 150
		CITY:			WOODSTOCK
		STATE:			GA
		ZIP:			30189
		BUSINESS PHONE:		800-759-9305

	MAIL ADDRESS:	
		STREET 1:		645 MOLLY LANE, SUITE 150
		CITY:			WOODSTOCK
		STATE:			GA
		ZIP:			30189

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oculus Innovative Sciences, Inc.
		DATE OF NAME CHANGE:	20060622
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sonoma_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: sonoma_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>sonoma_8k0501.htm
<DESCRIPTION>LEGAL OPINION
<TEXT>
Document 2 - file: sonoma_8k0501.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>sonoma_8k-ex1001.htm
<DESCRIPTION>AT THE MARKET OFFERING AGREEMENT
<TEXT>
Document 3 - file: sonoma_8k-ex1001.htm

</DOCUMENT>
</SEC-DOCUMENT>